Impact of in vivo complement activation and cryoglobulins on graft outcome of HCV-infected renal allograft recipients

Clinical Transplantation

Volumn 18, Issue 1, 2004, Pages 7-13

  Weiner, Stefan M ^a,b   Thiel, Jens ^b   Berg, Thomas ^c   Weber, Sabine ^b   Krumme, Bernd ^b   Peter, Hans H ^b   Rump, Lars C ^a   Gotz, Wolfgang H ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Complement 3d; Complement activation; Cryoglobulinemia; Cryoglobulins; Hepatitis C virus; Renal transplantation

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; COMPLEMENT COMPONENT C3D; CREATININE; CRYOGLOBULIN; CYCLOSPORIN; HEPATITIS C ANTIBODY; MYCOPHENOLIC ACID; PREDNISONE; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ADULT; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYOGLOBULINEMIA; FEMALE; GRAFT INFECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RECIPIENT; STATISTICAL SIGNIFICANCE; VASCULITIS;

ADULT; CASE-CONTROL STUDIES; COMPLEMENT ACTIVATION; COMPLEMENT C3D; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; CREATININE; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 1042304246     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00103.x     Document Type: Article

References (29)

1. Wintrobe M, Buell M. Hyperproteinemia associated with multiple myeloma. With report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud's disease. Bull Johns Hopkins Hosp 1933: 52: 156.
2. Brouet JC, Clauvel P-C, Danon F, Klein M, Seligman M. Biological and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974: 57: 775.
3. Weiner SM, Berg T, Berthold H et al. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol 1998: 29: 375.
4. Abel G, Zhang Q-X, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993: 36: 1341.
5. Mazzaro C, Tulissi P, Moretti M et al. Clinical and virological findings in mixed cryoglobulinaemia. J Int Med 1995: 238: 153.
6. Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology 1994: 106: 1291.
7. Pawlotsky JM, Ben Yahia M, Andre C et al. Immunological disorder in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994: 19: 841.
8. Wong VS, Egner W, Elsey T, Brown D, Alexander GJM. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996: 104: 25.
9. Roth D, Cirocco R, Zucker K et al. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995: 59: 1676.
10. Rother E, Lang B, Coldewey R, Hartung K, Peter HH. Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus. Clin Rheumatol 1993: 12: 31.
11. Kwok S, Higuchi R. Aoiding false positives with PCR. Nature 1989: 339: 237.
12. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes [letter]. Hepatology 1994: 19: 1321.
13. Van Thiel DH, Fagiuoli S, Caraceni P et al. Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol 1995: 22: 464.
14. Tanaka K, Aiyama T, Imai J, Morishita Y, Fukatsu T, Kakumu S. Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients. Am J Gastroenterol 1995: 90: 1847.
15. Rostaing L, Modesto A, Cisterne JM et al. Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C. Am J Nephrol 1998: 18: 50.
16. Wu M-J, Lan J-L, Shu K-H, Cheng C-H, Chen C-H, Lian J-D. Prevalence of subclinical cryoglobulinemia in maintanence hemodialysis patients and kidney transplant recipients. Am J Kidney Dis 2000: 35: 52.
17. Brunkhorst R, Kliem V, Koch KM. Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C. Nephron 1996: 72: 465.
18. Cruzado JM, Gil-Vernet S, Ercilla G et al. Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. J Am Soc Nephrol 1996: 7: 2469.
19. Cockfield SM, Prieksaitis JK. Infection with hepatitis C virus increases the risk of de novo glomerulonephritis in renal transplant recipients. J Am Soc Nephrol 1995: 6: 1078.
20. Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis Rheum 1999: 42: 2507
21. Bourke BE, Moss IK, Maini RN. Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis. J Immunol Methods 1982: 48: 97.
22. Corvetta A, Spaeth PJ, Ghirelli PA et al. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia. Diagnostic Immunol 1983: 1: 315.
23. Van Son WJ, Van Der Bij W, Tegzess AM et al. Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation? Clin Immunol Immunopathol 1989: 50: 109.
24. Van Son WJ, Van Der Woude FJ, Van Der Hem GK, The TH, Ockhuizen T, Tegzess AM. Complement activation associated with active cytomegalovirus infection in renal transplant patients, and its absence in transplant rejection episodes. Transplantation 1985: 39: 510.
25. Kirschfink M, Wienert T, Rother K, Pomer S. Complement activation in renal allograft recipients. Transplant Proc 1992: 24: 2556.
26. Muller TF, Kraus M, Neumann C, Lange H. Detection of renal allograft rejection by complement components C5A and TCC in plasma and urine. J Laboratory Clin Med 1997: 129: 62.
27. Sansonno D, Iacobelli AR, Cornacchiulo V et al. Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection. Eur J Clin Invest 1996: 26: 465.
28. Manzi S. Systemic lupus erythematosus: a model for atherogenesis? Rheumatology 2000: 39: 353.
29. Breitenfeldt MK, Rasenack J, Berthold H et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002: 16: 130.